Folium
| Autor: | Ting, Zhu, Bin-Yu, Fang, Xiang-Bao, Meng, Shu-Xia, Zhang, Hong, Wang, Ge, Gao, Fei, Liu, Yu, Wu, Jin, Hu, Gui-Bo, Sun, Xiao-Bo, Sun |
|---|---|
| Rok vydání: | 2022 |
| Předmět: |
Male
Dose-Response Relationship Drug Inflammasomes NF-E2-Related Factor 2 apoptosis Ginkgo biloba Infarction Middle Cerebral Artery Brain Ischemia Rats Rats Sprague-Dawley Random Allocation inflammation Pyrazines Reperfusion Injury NLR Family Pyrin Domain-Containing 3 Protein Animals oxidative stress Proto-Oncogene Proteins c-akt Ischaemic stroke Drugs Chinese Herbal Ischemic Stroke Research Article |
| Zdroj: | Pharmaceutical Biology article-version (VoR) Version of Record |
| ISSN: | 1744-5116 |
| Popis: | Context Folium Ginkgo extract and tetramethylpyrazine sodium chloride injection (Xingxiong injection) is a compound preparation commonly used for treating cerebral ischaemia/reperfusion injury in ischaemic stroke in China. However, its potential mechanisms on ischaemic stroke remain unknown. Objective This study explores the potential mechanisms of Xingxiong injection in vivo or in vitro. Materials and methods Sprague-Dawley (SD) rats were randomly assigned to five groups: the sham (normal saline), the model (normal saline) and the Xingxiong injection groups (12.5, 25 or 50 mL/kg). The rats were subjected to 2 h of middle cerebral artery occlusion (MCAO) followed by reperfusion for 14 d. Xingxiong injection was administered via intraperitoneal (i.p.) injection immediately after ischaemia induction for 14 d. Afterwards, rats were sacrificed at 14 d induced by administration of Xingxiong injection. Results Xingxiong injection significantly reduces infarct volume (23%) and neurological deficit scores (93%) compared with the MCAO/R group. Additionally, Xingxiong injection inhibits the loss in mitochondrial membrane potential (43%) and reduces caspase-3 level (44%), decreases NOX (41%), protein carbonyl (29%), 4-HNE (40%) and 8-OhdG (41%) levels, inhibits the expression of inflammatory factors, such as TNF-α (26%), IL-1β (34%), IL-6 (39%), MCP-1 (36%), CD11a (41%) and ICAM-1 (43%). Moreover, Xingxiong injection can increase p-Akt/Akt (35%) and Nrf2 (47%) protein expression and inhibit NLRP3 (42%) protein expression. Conclusions Xingxiong injection prevents cerebral ischaemia/reperfusion injury via activating the Akt/Nrf2 pathway and inhibiting NLRP3 inflammasome. These findings provide experimental evidence for clinical use of drugs in the treatment of ischaemic stroke. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|